Keyphrases
General Hospital
100%
Surabaya
96%
Indonesia
60%
Fibroblasts
48%
New Zealand White Rabbit
45%
Neoadjuvant Chemotherapy
44%
Locally Advanced Breast Cancer
39%
Collagen Density
38%
Predictive Factors
34%
Amniotic Membrane
34%
Breast Cancer Patients
33%
Complicated Intra-abdominal Infection (cIAI)
32%
Wound Healing
30%
Gastric Perforation
27%
Clinical Response
27%
Treatment Group
25%
Neutrophil-lymphocyte Ratio
24%
Laparotomy
22%
Neutrophil-to-lymphocyte Ratio
20%
Scoring System
20%
Tumor Necrosis Factor-α
20%
Cardiac Surgery
20%
Breast Cancer
19%
Peritonitis
19%
Pediatric Patients
19%
Ischemia-reperfusion Injury
19%
Anthracyclines
18%
Sepsis
17%
Abdominal
17%
Indonesian
17%
Young Males
17%
Type 1 Diabetes Mellitus (T1DM)
17%
Rattus Novergicus
17%
Biomaterials
17%
Neonate
16%
Albumin
16%
Mortality Prediction
16%
Locally Advanced Rectal Cancer
16%
Hirschsprung Disease
16%
Significant Relationship
16%
Retrospective Cohort Study
16%
Chemotherapy
15%
Postoperative Mortality
15%
Risk Factors
15%
COVID-19 Pandemic
14%
Anastomotic Leakage
14%
Perforation
14%
Healing
13%
Medical Records
13%
Penetrating Injury
13%
Operative
13%
Rattus Norvegicus
13%
Confidence Interval
13%
Collagen
12%
Colorectal Cancer
12%
Doxorubicin
12%
Surgeons
11%
PubMed
11%
Anastomosis
11%
Gastrointestinal Surgery
11%
Curcuma Longa
11%
Mortality Rate
11%
Vascular Endothelial Growth Factor
11%
Male Patients
11%
Cyclophosphamide
11%
Wound Healing Process
11%
5-fluorouracil (5-FU)
10%
Fascial Defect
10%
Lipid Emulsion
10%
Hemicolectomy
10%
Defect Closure
10%
Ludwig's Angina
10%
Wistar Strain
10%
Colorectal Anastomosis
10%
Vitamin C
10%
Radiological Response
10%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
10%
Peripheral Arterial Disease
10%
Tumor-infiltrating Lymphocytes
10%
Basal Cell Carcinoma
10%
Disease-free Interval
10%
Tumor
10%
Hemoglobin Level
10%
Metastatic Breast Cancer
10%
Sodium Chloride
10%
Patient Characteristics
10%
After Surgery
10%
Inclusion Criteria
10%
Intravenous Lipid Emulsion
10%
Etiology
9%
COVID-19
9%
Appendicitis
9%
No Significant Difference
9%
Post-chemotherapy
9%
Novel Scoring System
9%
Hemodialysis
9%
Comorbidity
9%
Albumin Level
8%
Ki-67
8%
Lymphocytes
8%
Medicine and Dentistry
Lymphocyte
45%
Fibroblast
43%
Neutrophil
41%
Wound Healing
38%
Neoadjuvant Chemotherapy
35%
Amnion
33%
Systematic Review
30%
Stomach Perforation
28%
Predictive Factor
28%
Abdominal Infection
27%
Heart Surgery
26%
Scoring System
24%
Locally Advanced Breast Cancer
21%
Pediatrics
21%
Laparotomy
21%
Biological Marker
21%
Diabetes Mellitus
21%
Peritonitis
20%
Surgery
19%
Neoplasm
19%
Biocompatible Material
18%
Pediatrics Patient
18%
Penetrating Trauma
18%
Recurrent Disease
16%
Rectum Cancer
16%
Reperfusion Injury
16%
Basal-Cell Carcinoma
16%
Neck
15%
Treatment Group
15%
Diseases
15%
Retrospective Cohort Study
15%
Anastomosis Leakage
15%
Surgical Mortality
14%
C Reactive Protein
14%
Mortality Rate
13%
Surgeon
13%
Infection
13%
Breast Cancer
12%
Antiinfective Agent
12%
Physical Examination
12%
Wound
11%
Sepsis
11%
Colorectal Carcinoma
11%
COVID-19
10%
Doxorubicin
10%
Colon Anastomosis
10%
Choledochal Cysts
10%
Anthracycline
10%
Lipid Emulsion
10%
Gastrointestinal Surgery
10%
Hemicolectomy
10%
Ludwig's Angina
10%
Curcuma Longa Extract
10%
Prospective Study
10%
Arteriosclerosis Obliterans
10%
Aponeurosis
10%
Trachea
10%
Randomized Controlled Trial
10%
Neonate
10%
Hemodialysis
10%
Observational Study
10%
Meta-Analysis
9%
Comorbidity
9%
Tumor Necrosis Factor
9%
Appendix Perforation
9%
Hospital Mortality
9%
Odds Ratio
8%
Traffic Accident
8%
Cross Sectional Study
8%
Appendicitis
8%
Jaundice
8%
Diagnostic Error
8%
Foreign Body
8%
Radiation Therapy
8%
Surgical Infection
8%
Pancreaticoduodenectomy
7%
Necrosis
7%
Prevalence
7%
Bleeding
7%
Perforated Ulcer
7%
Turmeric
7%
Adolescence
7%
Wound Infection
7%
Suture
6%
Cancer Surgery
6%
Medium Chain Triacylglycerol
6%
Long Chain Triacylglycerol
6%
Acute Kidney Injury
6%
Hirschsprung's Disease
6%
Lactic Acid
6%
Jejunum Ulcer
6%
Intestine Anastomosis
6%
In Vitro
6%
Congenital Malformation
6%
Survival Rate
6%
Colon Carcinoma
6%
Injury
6%
Stem Cell
6%
Endoscopic Retrograde Cholangiopancreatography
6%
Recurrence Risk
6%